Marker Therapeutics Stock Market Value
| MRKR Stock | USD 1.24 0.06 5.08% |
| Symbol | Marker |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Marker Therapeutics. If investors know Marker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Marker Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Marker Therapeutics is measured differently than its book value, which is the value of Marker that is recorded on the company's balance sheet. Investors also form their own opinion of Marker Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Marker Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Marker Therapeutics' market value can be influenced by many factors that don't directly affect Marker Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Marker Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Marker Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marker Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Marker Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Marker Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Marker Therapeutics.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Marker Therapeutics on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Marker Therapeutics or generate 0.0% return on investment in Marker Therapeutics over 90 days. Marker Therapeutics is related to or competes with Exicure, Protagenic Therapeutics, Pmv Pharmaceuticals, Anebulo Pharmaceuticals, Agenus, Edgewise Therapeutics, and RenovoRx. Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of... More
Marker Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Marker Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Marker Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 49.05 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 8.27 |
Marker Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Marker Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Marker Therapeutics' standard deviation. In reality, there are many statistical measures that can use Marker Therapeutics historical prices to predict the future Marker Therapeutics' volatility.| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.62) | |||
| Total Risk Alpha | (0.69) | |||
| Treynor Ratio | (2.69) |
Marker Therapeutics Backtested Returns
Marker Therapeutics has Sharpe Ratio of -0.21, which conveys that the firm had a -0.21 % return per unit of risk over the last 3 months. Marker Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Marker Therapeutics' Standard Deviation of 8.01, mean deviation of 5.72, and Risk Adjusted Performance of (0.17) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.63, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Marker Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Marker Therapeutics is expected to be smaller as well. At this point, Marker Therapeutics has a negative expected return of -1.68%. Please make sure to verify Marker Therapeutics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Marker Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.76 |
Good predictability
Marker Therapeutics has good predictability. Overlapping area represents the amount of predictability between Marker Therapeutics time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Marker Therapeutics price movement. The serial correlation of 0.76 indicates that around 76.0% of current Marker Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Marker Therapeutics lagged returns against current returns
Autocorrelation, which is Marker Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Marker Therapeutics' stock expected returns. We can calculate the autocorrelation of Marker Therapeutics returns to help us make a trade decision. For example, suppose you find that Marker Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Marker Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Marker Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Marker Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Marker Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Marker Therapeutics Lagged Returns
When evaluating Marker Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Marker Therapeutics stock have on its future price. Marker Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Marker Therapeutics autocorrelation shows the relationship between Marker Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Marker Therapeutics.
Regressed Prices |
| Timeline |
Additional Tools for Marker Stock Analysis
When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.